Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 6-oxa-3,9,15-triaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents

6-oxa-3,9,15-triaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents

US Patent 10494379 · Granted Dec 3, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of2021
2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of2021
2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of2021
2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of2021
2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of2021
2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of2021
2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of2021
3,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compo2021
3,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compo2021
3,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compo2021
3,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compo2021
3,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compo2021